Clinical Trial

SpO2 Infant and Pediatric Study

Study acronym: SpO2 Peds
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability of usable data, performance across skin tones, and user feedback.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-28.
Trial Details
NCT Number NCT07615738
Lead Sponsor GE Healthcare
Conditions SpO2 (Peripheral Oxygen Saturation) Measurement Validation, SpO2
Enrollment 180 participants
Start Date 2026-06-15
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01